Einfach Bitcoin kaufen: Mit dem Code "FINANZEN" sparen Sie 21% der Gebühren für 6 Monate bei Coinfinity. Jetzt loslegen -w-
28.07.2021 00:08:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SYKE, TGRF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 27, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

logo (PRNewsfoto/Halper Sadeh LLP)

Sykes Enterprises, Incorporated (NASDAQ: SYKE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sitel Group for $54.00 per share. If you are a Sykes shareholder, click here to learn more about your rights and options. 

TGR Financial, Inc. (OTCQX: TGRF) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Foundation Inc. Under the terms of the merger agreement, TGR Financial shareholders will receive 0.6068 shares of First Foundation common stock for each share of TGR Financial common stock or TGR Financial Series A non-voting convertible preferred stock. Upon closing, TGR Financial shareholders are expected to own approximately 20.2% of the outstanding shares of First Foundation's common stock. If you are a TGR Financial shareholder, click here to learn more about your rights and options.  

1Life Healthcare, Inc. (NASDAQ: ONEM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction. Upon closing, 1Life Healthcare shareholders are expected to own approximately 73.25% of the combined company. If you are a 1Life Healthcare shareholder, click here to learn more about your rights and options.  

Kindred Biosciences, Inc. (NASDAQ: KIN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Elanco Animal Health Incorporated for $9.25 per share. If you are a Kindred Biosciences shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llp-investigates-syke-tgrf-onem-kin-shareholders-are-encouraged-to-contact-the-firm-301342454.html

SOURCE Halper Sadeh LLP

Nachrichten zu Kindred Biosciences Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Kindred Biosciences Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!